Skip to main content

Table 1 Characteristics of study subjects according to the presence of two or more metabolic risk factors except WC in elderly Koreans

From: The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study

   Men   Women
  Total Two or more metabolic risk factors of the modified NCEP-ATP III of the criteria except WC Total Two or more metabolic risk factors of the modified NCEP-ATP III of the criteria except WC
   Absent Present   Absent Present
N (%) 308 105 (34.1) 203 (65.9) 381 101 (26.5) 280 (73.5)
Age (years) 71.2 ± 5.2 70.6 ± 5.1 71.6 ± 5.3 70.5 ± 4.7 70.5 ± 5.0 70.5 ± 4.7
Body mass index (kg/m2) 24.0 ± 2.8 22.6 ± 2.4 24.7 ± 2.7* 25.0 ± 3.1 23.4 ± 3.4 25.6 ± 2.8*
Waist circumference (cm) 88.0 ± 7.6 83.9 ± 7.0 90.2 ± 7.0* 88.5 ± 8.3 84.6 ± 9.1 90.0 ± 7.5*
VFA (cm2) 103.6 ± 49.1 78.3 ± 40.4 116.7 ± 48.2* 108.9 ± 45.4 84.0 ± 37.5 117.9 ± 44.7*
SFA (cm2) 157.1 ± 50.9 138.6 ± 47.5 166.7 ± 50.1* 239.4 ± 67.8 215.5 ± 74.9 248.0 ± 63.0*
Fasting glucose (mg/dl) 96.5 ± 17.0 90.0 ± 8.9 99.8 ± 19.0* 95.8 ± 21.1 88.1 ± 10.6 98.5 ± 23.1*
post 2 hr OGTT-glucose (mg/dl) 129.5 ± 50.8 103.7 ± 34.0 145.5 ± 52.9* 138.5 ± 51.7 109.1 ± 27.2 150.9 ± 54.5
High glucose (n, (%))a 151 (49.0) 15 (14.3) 136 (67.0)* 187 (49.1) 10 (9.9) 177 (63.2)*
Taking oral hypoglycemic medication or insulin (n,(%)) 41(13.3) 3 (2.9) 38 (18.7)* 44 (13.6) 3 (3.0) 41 (14.6)*
Systolic blood pressure 129.4 ± 15.6 123.2 ± 16.2 132.6 ± 14.3* 127.3 ± 16.1 120.0 ± 13.4 129.9 ± 16.2*
Diastolic blood pressure 76.1 ± 8.5 73.9 ± 7.5 77.3 ± 8.7* 75.2 ± 8.0 72.1 ± 8.1 76.3 ± 7.7*
High blood pressure (n, (%))b 205 (66.6) 35 (33.3) 170 (83.7)* 249 (65.4) 35 (34.7) 214 (76.4)*
Taking antihypertensive medication (n, (%)) 140(45.5) 20 (19.1) 120 (59.2)* 185 (48.6) 21 (20.8) 164 (58.6)*
Triglycerides (mg/dl) 137.1 ± 80.9 97.9 ± 29.3 157.4 ± 91.0* 146.5 ± 80.9 92.2 ± 26.9 166.0 ± 84.9*
Hypertriglyceridemia (n, (%))c 96 (31.2) 5 (4.8) 91 (44.8)* 138 (36.2) 1 (1.0) 137 (48.9)*
HDL cholesterol (mg/dl) 41.0 ± 10.2 46.8 ± 9.4 38.1 ± 9.2* 43.1 ± 10.4 51.6 ± 9.8 40.0 ± 8.8*
Low HDL cholesterol (n,(%))d 159 (51.6) 16 (15.2) 143 (70.4)* 286 (75.1) 39 (38.6) 247 (88.2)*
Taking lipid-lowering medication (n, (%)) 31 (10.1) 8 (7.6) 23 (11.3) 44 (11.6) 10 (9.9) 34 (12.1)
  1. Data are mean ± S.D. or %. VFA, Visceral abdominal fat area; SFA, Subcutaneous abdominal fat area
  2. aHigh glucose was diagnosed if fasting glucose ≥100 mg/dl or post 2 hr OGTT-glucose ≥140 mg/dl or the subjects with oral hypoglycemic medication or insulin.
  3. bHigh blood pressure was diagnosed if systolic blood pressure was ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or the subjects with antihypertensive medications.
  4. cHypertriglyceridemia was diagnosed if triglycerides was ≥150 mg/dl in men and women.
  5. dLow HDL cholesterol was diagnosed if HDL cholesterol was < 40 mg/dl in men and < 50 mg/dl in women.
  6. *: p <0.01 compared with subjects without two or more metabolic risk factors in each gender.
  7. : p < 0.01 compared with men.